Literature DB >> 7524519

MHC class II signaling in B-cell activation.

P R Scholl1, R S Geha.   

Abstract

The cognate interaction between T cells and antigen-presenting cells (APCs), mediated by major histocompatibility complex (MHC) class II molecules, results in the delivery of activation signals to the APC. These signals contribute to the expression of co-stimulatory activity by APCs and have important consequences for cell effector function. MHC class II molecules also serve as receptors for B-cell stimulation by microbial superantigens. In this review, Paul Scholl and Raif Geha discuss recent advances in our understanding of mechanisms of MHC class II signaling and analyse their role in human B-cell activation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524519     DOI: 10.1016/0167-5699(94)90271-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  19 in total

1.  Expression of MHC class II in T cells is associated with increased HIV-1 expression.

Authors:  M Saifuddin; G T Spear; C Chang; K A Roebuck
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

2.  Immune Activation: Contribution to AIDS-Associated Non-Hodgkin Lymphoma.

Authors:  Marta Epeldegui; Otoniel Martínez-Maza
Journal:  For Immunopathol Dis Therap       Date:  2015

3.  Characterization of a humanized IgG4 anti-HLA-DR monoclonal antibody that lacks effector cell functions but retains direct antilymphoma activity and increases the potency of rituximab.

Authors:  Rhona Stein; Zhengxing Qu; Susan Chen; David Solis; Hans J Hansen; David M Goldenberg
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

Review 4.  Targeting mucosal immunity in the battle to develop a mastitis vaccine.

Authors:  Mini Bharathan; Isis K Mullarky
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-10-04       Impact factor: 2.673

5.  Modulation of major histocompatibility complex protein expression by human gamma interferon mediated by cysteine proteinase-adhesin polyproteins of Porphyromonas gingivalis.

Authors:  P L Yun; A A DeCarlo; N Hunter
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

6.  Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.

Authors:  Q Li; M K Spriggs; S Kovats; S M Turk; M R Comeau; B Nepom; L M Hutt-Fletcher
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

Review 7.  HIV-associated immune dysfunction and viral infection: role in the pathogenesis of AIDS-related lymphoma.

Authors:  Marta Epeldegui; Elena Vendrame; Otoniel Martínez-Maza
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 8.  The use of signal peptide domains as vaccine candidates.

Authors:  Riva Kovjazin; Lior Carmon
Journal:  Hum Vaccin Immunother       Date:  2014-10-30       Impact factor: 3.452

9.  MHC class II cell-autonomously regulates self-renewal and differentiation of normal and malignant B cells.

Authors:  Julia Merkenschlager; Urszula Eksmond; Luca Danelli; Jan Attig; George R Young; Carla Nowosad; Pavel Tolar; George Kassiotis
Journal:  Blood       Date:  2019-01-30       Impact factor: 22.113

10.  A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.

Authors:  J Villard; M Peretti; K Masternak; E Barras; G Caretti; R Mantovani; W Reith
Journal:  Mol Cell Biol       Date:  2000-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.